Insta
IIT Hyderabad Researchers Develop Oral Tablets Of Amphotericin B To Treat Post-Covid Fungus Infection
Swarajya Staff
May 30, 2021, 12:46 PM | Updated 12:46 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
In a positive development, the Indian Institute of Technology (IIT) Hyderabad has developed nano-fibre based controlled-release oral tablets of Amphotericin B (AmB) to treat fungal infections arising out of COVID-19, reports Economic Times.
It should be noted that as of present, AmB is an injectable drug. The researchers from IIT Hyderabad have decided to keep the technology free of intellectual property rights. They are also looking at partnering with pharmaceutical players for mass-scale production.
It should be noted that as per IIT Hyderabad faculty member Saptarshi Majumdar, “AmB has poor aqueous solubility and forms aggregates in the system, which stresses renal filtration and thus causes nephrotoxicity (toxic for kidneys).”
Back in 2019, Majumdar and his colleague Chandra Shekhar Sharma from the institute’s Department of Chemical Engineering had released a study that oral nanofibrous AmB can be effective to treat kala-azar, a parasitic ailment that can cause fever, weight loss and swelling of the liver or the spleen. This was a first-ever attempt to fabricate nanofibrous oral tablets of amphotericin B for the potential cure of kala-azar or leishmaniasis.
They have expressed confidence that the technology can be transferred to suitable pharmaceutical partners for large-scale production.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.